| Product Name | NebuSelect™ Recombinant Human B7-H4, hFc-tag |
|---|---|
| Catalog Number | NBL-243027 |
| Alias/Synonyms | B7-H4; B7H4; B7-H4; B7S1; B7h.5; B7x; FLJ22418; VTCN1; PRO1291 |
| Appearance | see COA |
| Molecule Weight | |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | Q7Z7D3-1 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-243027-100ug | 100ug | Inquire | Inquire | |
| NBL-243027-1mg | 1mg | Inquire | Inquire | |
| NBL-243027-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human B7-H4, hFc-tag
Catalog#:
NBL-243027
Description:
NebuSelect™ Recombinant Human B7-H4, hFc-tag(Cat#NBL-243027) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Phe29-Ala258.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 52.1 kDa. Due to glycosylation, the protein migrates to 70-80 kDa based on Bis-Tris PAGE result.
Target Name:
B7-H4; B7H4; B7-H4; B7S1; B7h.5; B7x; FLJ22418; VTCN1; PRO1291
Target Information:
B7-H4, also known as B7x and B7S1, is a 50-80 kDa glycosylated member of the B7 family of immunomodulatory proteins.B7-H4 is up-regulated in several carcinomas in correlation with tumor progression and metastasis. A soluble form of B7-H4 is elevated in the serum of ovarian cancer, renal cell carcinoma, and rheumatoid arthritis patients, also in correlation with advanced disease status-.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.